Rinicare Limited, a Manchester, UK-based intelligent healthcare company, completed its financing round.
Backers included new investors Catapult Ventures and NPIF – Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund.
The company intends to use the funds to for the commercialization of its digital healthcare portfolio, which is designed to provide solutions that improve outcomes and reduce costs in a number of settings, such as emergency, primary and community care, as well as progress its AI-powered predictive algorithm for intensive care.
Led by Stuart Hendry, CEO, Rinicare is an intelligent healthcare company that develops and markets healthcare products based on its proprietary wireless communications, predictive algorithms, artificial intelligence (AI), computer vision, IoT and big data, which can be used in a wide range of medical applications.
The company markets its wireless physiological signs technology (PRIME) and its falls prevention system (SAFE) globally in a number of healthcare solutions, which are tailored to individual needs.
In addition to its expanding marketed solutions, Rinicare is developing its AI predictive system, Stability, which is initially focused on intensive care and addresses a global market for predictive healthcare analytics.
The company, headquartered in Alderley Park, Manchester, UK and has R&D capabilities in Lancaster, UK and Ramada, Portugal, has a number of existing distributors globally and is actively seeking new partnerships.